Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, with tumor necrosis factor (TNF)-α playing a key role in its pathogenesis. Etanercept, a decoy receptor for TNF, is used to treat inflammatory conditions. The secretome derived from adipose-derived stem cells (ASCs) has anti-inflammatory effects, making it a promising therapeutic option for IBD.

中文翻译：

---

依那西普合成脂肪干细胞分泌组：炎症性肠病的一种有前途的治疗选择。

炎症性肠病（IBD）是一种胃肠道慢性炎症性疾病，肿瘤坏死因子（TNF）-α在其发病机制中发挥着关键作用。依那西普是 TNF 的诱饵受体，用于治疗炎症。源自脂肪干细胞 (ASC) 的分泌蛋白组具有抗炎作用，使其成为 IBD 有前景的治疗选择。